The use of the Chuang′s prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy

Alsirafy, Samy A.; Zaki, Omar; Sakr, Amr; Farag, Dina E.; El-Sherief, Wessam A.; Mohammed, Abha A

doi:10.4103/0973-1075.185043

Cited by 2 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent study found that using an assessment tool—the palliative prognostic score (PaP)—was significantly more accurate in determining both 30- and 100-day survival when compared to using the tool combined with clinician prediction, and to clinician assessment alone [ 8 ]. Other studies have also shown objective assessment to be more accurate than clinician gestalt regarding prognosis, particularly when prognosticating 3 months or less into the future [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

The Intersection of Oncology Prognosis and Cancer Rehabilitation

Smith

Zheng

2017

Curr Phys Med Rehabil Rep

View full text Add to dashboard Cite

Purpose of reviewThis review examines the delivery of rehabilitation care to cancer patients with relation to disease prognosis. This includes the evaluation when patients are referred for rehabilitation services and the effectiveness of rehabilitation interventions across the cancer continuum.Recent findingsAlthough prognosticating life expectancy is difficult, referrals for rehabilitation interventions appear to be affected by physician attitudes towards patients with advanced disease, in part because of misconceptions about the nature of rehabilitation for oncology patients. Rehabilitation may also be underutilized in long-term survivors with no evidence of disease. Despite this, our review found that rehabilitation in advanced disease, end-of-life, geriatric cancer patients, and in long-term survivors can be beneficial. There is a relative dearth in studies on rehabilitation interventions specifically at the end-of-life.SummaryCancer rehabilitation can be helpful to patients along the spectrum of cancer prognoses. Examining more accurate ways to prognosticate life expectancy, improving communication and education between oncologists and rehabilitation team members, and modifying survivorship plans to include patient education on functional changes over time may improve the delivery of rehabilitation care.

show abstract

Section: Introductionmentioning

confidence: 99%

The Intersection of Oncology Prognosis and Cancer Rehabilitation

Smith

Zheng

2017

Curr Phys Med Rehabil Rep

View full text Add to dashboard Cite

show abstract

“…The authors reported that patients with a high score (>5) were associated with poor survival (61 days) compared with 149 days for those with CPS ≤5. [ 8 ]…”

Section: Discussionmentioning

confidence: 99%

Prediction of survival outcome using Chuang's prognostic scale in metastatic breast cancer

Mohammed

Al-Zahrani

Elsayed

et al. 2021

Indian J Palliat Care

View full text Add to dashboard Cite

Background: For physicians and patients, survival estimation is vital for the treatment plan, especially with frequent use of new therapeutic agents in metastatic breast cancer (MBC). The Chuang's Prognostic Scale (CPS) is a validated prognostic score that may be useful in the avoidance of unnecessary palliative systemic treatment. Aim: The present study aimed to evaluate the CPS in survival prediction in patients with MBC after at least two lines of palliative systemic chemotherapy protocols (PSCPs). Methods: CPS was prospectively measured in 221 patients with MBC. The total score ranged from 0 to 8.5; the lower score refers to a good prognosis. The survival assessment was made by the Kaplan–Meier curve and the survival difference among the groups was estimated by log-rank test. Results: Using the cutoff value of CPS 5.7, the patients were classified into two groups: Group A had score ≤5.7 (174 patients, 78.7%) and Group B had CPS score >5.7 (47 patients, 21.3%). About 86.2% of the patients in Group A survived >3 months (median survival was 165 days, 95% confidence interval [CI]: 77–261) compared with 21.3% of patients survived in Group B (median survival was 81 days, 95% CI: 55–123) ( P = 0.00). The sensitivity, specificity, positive predictive value, and negative predictive value were 97.6% (95% CI: 87.4–99.9), 98.3% (95% CI: 95.2–99.7), 93.2% (95% CI: 81.6–97.7), and 99.4% (95% CI: 96.2–99.9), respectively, for the 3-month mortality prediction. Conclusion: CPS could be helpful in estimating the survival outcome in patients with MBC who received at least two PSCPs.

show abstract

The use of the Chuang′s prognostic scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy

Cited by 2 publications

References 16 publications

The Intersection of Oncology Prognosis and Cancer Rehabilitation

The Intersection of Oncology Prognosis and Cancer Rehabilitation

Prediction of survival outcome using Chuang's prognostic scale in metastatic breast cancer

Contact Info

Product

Resources

About